Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Up 4.4% – Should You Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s stock price were up 4.4% on Friday . The stock traded as high as $18.86 and last traded at $18.30. Approximately 6,240 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 26,930 shares. The stock had previously closed at $17.53.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on TLX shares. UBS Group increased their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. William Blair reissued an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The business has a fifty day moving average of $17.63.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.